Robert Nelsen
10% Owner; Director, 10% Owner · 6 filings · Latest: Jun 22, 2026
Kardigan, Inc.
Lyell Immunopharma, Inc.
Prime Medicine, Inc.
Sana Biotechnology, Inc.
Seaport Therapeutics, Inc.
| Ticker | Owner | Relationship | Date | Transaction | Cost | #Shares | Value ($) | #Shares Total | SEC Filing |
|---|---|---|---|---|---|---|---|---|---|
KARD | Robert Nelsen | Director, 10% Owner | Jun 22, 2026 | Purchase | $16.00 | 1,250,000 | $20.0M | 15,042,035 | |
SPTX | Robert Nelsen | 10% Owner | May 4, 2026 | Purchase | $18.00 | 1,100,000 | $19.8M | 6,294,951 | |
LYEL | Robert Nelsen | 10% Owner | Mar 6, 2026 | Purchase | $25.61 | 488,090 | $12.5M | 1,426,528 |